KLR Investment Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,118
Closed -$343K 193
2023
Q4
$343K Sell
1,118
-192
-15% -$51.8K 0.25% 123
2023
Q3
$246K Buy
1,310
+3
+0.2% +$767 0.22% 154
2023
Q2
$314K Sell
1,307
-50
-4% -$10.4K 0.26% 130
2023
Q1
$255K Sell
1,357
-200
-13% -$41.4K 0.22% 152
2022
Q4
$331K Buy
+1,557
New +$311K 0.27% 126

Other funds holding MEDP

KLR Investment Advisors's MEDP Position: Q1 2024 in Review

KLR Investment Advisors sold out of Medpace (MEDP) in Q1 2024, closing a stake of 1,118 shares — an estimated $343K sold.

KLR Investment Advisors first reported a position in MEDP in Q4 2022 and held it in 5 quarters. The position peaked at $343K in Q4 2023. 597 funds tracked by Wall St. Rank hold MEDP as of Q1 2024.

  • KLR Investment Advisors reported no remaining Medpace position as of Q1 2024 after selling out during the quarter.
  • KLR Investment Advisors sold 1,118 Medpace shares in Q1 2024, an estimated $343K.
  • KLR Investment Advisors first reported a position in Medpace in Q4 2022 and held it in 5 quarters.
  • KLR Investment Advisors's Medpace position peaked at $343K in Q4 2023.
  • 597 funds tracked by Wall St. Rank held Medpace as of Q1 2024.

Based on KLR Investment Advisors's 13F filing for Q1 2024, filed 23 Apr 2024.